EUVIMEDEUVIMED entdecken
Open Access

Adaptive immune cells antagonize ILC2 homeostasis via SLAMF3 and SLAMF5

Yuande Wang iD, Dan Li iD, Yehai Liu iD, Shasha Chen iD, Zhongjun Dong iD

Science Advances · 2025

DOI: 10.1126/sciadv.adp9894 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Yuande Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Allergy, the First Affiliated Hospital of Anhui Medical University and Institute of Clinical Immunology, Anhui Medical University, Hefe…. Hauptthemen laut MEDLINE: Homeostasis, Signaling Lymphocytic Activation Molecule Family, Adaptive Immunity, Immunity, Innate. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 innate lymphoid cells (ILC2s) mainly reside in tissues with few lymphoid cells. How their tissue residency is regulated remains poorly understood. This study explores the inhibitory role of SLAM-family receptors (SFRs) on adaptive immune cells in ILC2 maintenance. We observed an increase in the population of ILC2s in Rag1-deficient mice. Homotypic engagement of SFRs between ILC2s and adaptive immune cells was identified as a potential mechanism. SFR deficiency led to an increase in ILC2s. Conditional deletion of SFRs on T and/or B cells led to an increased ILC2 abundance. Mechanistically, as ILC precursors differentiate into ILC2s, SFRs, primarily SLAMF3 and SLAMF5, are inhibitory, which impair IL-7–induced PI3K activation and enhance apoptosis via SHP-1. These findings reveal a mechanism by which adaptive immune cells negatively regulate the homeostasis of ILC2s and contribute to our understanding of the complex interplay between innate and adaptive immune cells in the regulation of immune responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HomeostasisSignaling Lymphocytic Activation Molecule FamilyAdaptive ImmunityImmunity, InnateLymphocytesAnimalsMiceMice, KnockoutApoptosisProtein Tyrosine Phosphatase, Non-Receptor Type 6Interleukin-7Mice, Inbred C57BLPhosphatidylinositol 3-Kinases

Substanzen

Signaling Lymphocytic Activation Molecule FamilyProtein Tyrosine Phosphatase, Non-Receptor Type 6Interleukin-7Phosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • Department of Allergy, the First Affiliated Hospital of Anhui Medical University and Institute of Clinical Immunology, Anhui Medical University, Hefei 230032, China.
  • State Key Laboratory of Membrane Biology, School of Medicine and Institute for Immunology, Tsinghua University, Beijing 100084, China.
  • Innovative Institute of Tumor Immunity and Medicine (ITIM), Hefei 230032, China.
  • Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy, Hefei 230032, China.
  • Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei 230032, China.

ORCID-Profile: Yuande Wang, Dan Li, Yehai Liu, Shasha Chen, Zhongjun Dong

Zitieren

APA

Wang, Y., Li, D., Liu, Y., Chen, S., & Dong, Z. (2025). Adaptive immune cells antagonize ILC2 homeostasis via SLAMF3 and SLAMF5. Science Advances. https://doi.org/10.1126/sciadv.adp9894

Vancouver

Wang Y, Li D, Liu Y, Chen S, Dong Z. Adaptive immune cells antagonize ILC2 homeostasis via SLAMF3 and SLAMF5. Science Advances. 2025. doi:10.1126/sciadv.adp9894

BibTeX
@article{Wang2025,
  author = {Wang, Yuande and Li, Dan and Liu, Yehai and Chen, Shasha and Dong, Zhongjun},
  title = {Adaptive immune cells antagonize ILC2 homeostasis via SLAMF3 and SLAMF5},
  journal = {Science Advances},
  year = {2025},
  doi = {10.1126/sciadv.adp9894}
}
Kostenlos starten →